Loading asset research
Wave Life Sciences Inc. Common Stock
WVENasdaq · USD · StocksQuote as of · Exchange session not verified$4.59
-1.82%
Today
WVE
Loading 1D prices…
Market cap
$904.5M
Volume
2.2M
52w high
$21.7352w low
$4.56Company profile
Wave Life Sciences Inc. Common Stock
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington's disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Cambridge, MA, United States
Employees
317
Fiscal year end
1231
CIK
1631574
Session & valuation
Open$4.67
Previous close$4.67
Day high$4.72
Day low$4.56
30-day avg. volume3.4M
Outstanding shares197M
Diluted EPS-$1.21
Latest annual period
P/E (trailing)-3.79
P/E (forward)-4.04
Price / book1.66
Beta-1.30
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| OLMAOlema Pharmaceuticals Inc. Common Stock | $894.2M | $0.00 | — | -$1.87 | -4.30% | Buy |
| DSGNDesign Therapeutics Inc. Common Stock | $915.6M | $0.00 | — | -$1.22 | -1.01% | Buy |
| LXRXLexicon Pharmaceuticals Inc. Common Stock | $889.9M | $49.8M | -101.08% | -$0.14 | -1.24% | Buy |
| ARDXArdelyx Inc. Common Stock | $924.3M | $407.3M | -15.22% | -$0.26 | -1.24% | Buy |
| TBPHTheravance Biopharma Inc. Ordinary Shares | $883.1M | $107.5M | +98.54% | $2.06 | -0.00% | Hold |